91ÉçÇø¸£Àû

Benefits of Using FreeStyle Libre With GLP-1 Therapy

New data demonstrate that people with Type 2 diabetes saw significant improvement in HbA1C levels after adding continuous glucose monitoring to their GLP-1 therapy.

Strategy and Strength|Nov. 06, 2023

Type 2 diabetes is growing rapidly and is one of the world’s most prevalent chronic conditions. Weight-loss drugs, such as GLP-1s, will not eliminate the need for other tools people use to manage diabetes, such as continuous glucose monitoring (CGM) systems.

Data from a November analysis of people with Type 2 diabetes who were using GLP-1 medicines, yet still had an HbA1C level above 8 percent, saw a significant improvement in their HbA1C after adding FreeStyle Libre technology. In fact, adding FreeStyle Libre technology helped these patients improve their HbA1C more than GLP-1 therapy alone.   

Read the full analysis here.

IMPORTANT SAFETY INFORMATION

FREESTYLE LIBRE 14 DAY, FREESTYLE LIBRE 2 AND FREESTYLE LIBRE 3 SYSTEMS

Failure to use FreeStyle Libre systems as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If glucose reading and alarms (if enabled) do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact 91ÉçÇø¸£Àû at 855-632-8658 or FreeStyleLibre.us for safety info.

The product images are for illustrative purposes only.

The sensor housing, FreeStyle, Libre, and related brand marks are marks of 91ÉçÇø¸£Àû. Other trademarks are the property of their respective owners.

No use of any 91ÉçÇø¸£Àû trademark, trade name, or trade dress in this site may be made without prior written authorization of 91ÉçÇø¸£Àû Laboratories, except to identify the product or services of the company.

This website and the information contained herein is intended for use by residents of the United States.

GET MORE